Zach Bush, MD

Zach Bush, MD

Charlottesville, Virginia, United States
5K followers 500+ connections

About

Zach Bush, MD is a physician specializing in internal medicine, endocrinology and hospice…

Activity

Join now to see all activity

Experience

Education

Licenses & Certifications

Volunteer Experience

  • Physician Leader

    US Navy Ship Comfort

    - Present 14 years 7 months

    Disaster and Humanitarian Relief

    Physician leader, US Navy Ship Comfort, Haiti Relief Operation.
    Director of pre- and post-surgical care.
    February, 2010. Port-au-Prince, Haiti

Publications

  • Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcomes with DNA Methylation and MGMT Expression.

    J Clin Endocrinol Metab.

    Bush ZM, Longtine JA, Cunningham T, Schiff D, Jane, Jr. JA, Vance ML, Thorner MO, Laws, Jr. ER, Lopes MB.

    Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcomes with DNA
    Methylation and MGMT Expression.

    [Original Research]

    J Clin Endocrinol Metab.

    2010 Nov;95(11):E280-90

  • Immunohistochemistry of COUP-TFI: An adjuvant diagnostic tool for the identification of corticotroph microadenomas.

    Bush ZM, Lopes MBS, Hussaini IM, Jane, Jr JA, Laws ER, Vance ML.

    Immunohistochemistry of COUP-TFI: An adjuvant diagnostic tool for the identification of corticotroph microadenomas.

    [Original Research]

    Pituitary.

    2010;13:1-7.

  • Management of acromegaly: Is there a role for primary medical therapy?

    Bush ZM, Vance ML.

    Management of acromegaly: Is there a role for primary medical therapy?

    [Review]

    Rev Endocr Metab Disord.

    2008 Mar;9(1):83-94.

  • Acute pancreatitis in HIV-infected patients: are etiologies changing since the introduction of protease inhibitor therapy?

    Bush ZM, Kosmiski L.

    Acute pancreatitis in HIV-infected patients: are etiologies changing since the introduction of protease inhibitor therapy?

    [Original Research]

    Pancreas. 27(1):E1-5, 2003 Jul.

  • Endocrine Complications After Skull Based Endoscopic Surgery.

    Thieme Medical Publishers Inc.

    Book Publication

    Bush ZM, Vance ML, Jane, Jr. JA.

    Endocrine Complications After Skull Based Endoscopic Surgery.

    Chapter 47. ENDOSCOPIC SKULL BASE AND BRAIN SURGERY: TIPS AND PEARLS by Aldo
    Stamm.

    Thieme Medical Publishers Inc.

    New York, New York.

    In press.

  • Expert Review of Pharmacoeconomics & Outcomes Research Case Reports in Medicine Virchows Archive

    -

    Invited Reviewer for peer-reviewed journals:
    Expert Review of Pharmacoeconomics & Outcomes Research Case Reports in Medicine Virchows Archive

  • Gliadin and glyphosate independently, and in combination, induce tight junction injury, and epithelial membrane leak in small bowel and colon epithelial membrane.

    J Gastroenterology

    Gildea J, Roberts D, Bush ZM (as Senior/corresponding author).

    Gliadin and glyphosate independently, and in combination, induce tight junction injury, and epithelial membrane leak in small bowel and colon epithelial membrane.

    [Self-Funded Original Research]

    (Under Review J Gastroenterology).

  • Protection against Gluten-mediated Tight Junction Injury with a Novel Lignite Extract Supplement.

    J Nutr Food

    Gildea J, Roberts D, Bush ZM (as Senior/corresponding author).

    Protection against Gluten-mediated Tight Junction Injury with a Novel Lignite Extract Supplement.

    [Self-Funded Original Research]

    J Nutr Food

    Sci 2016, 6:5

  • Protective Effects of Lignite Extract Supplement on Intestinal Barrier Function in Glyphosate-mediated Tight Junction Injury.

    BioMed Central – Public Health

    Gildea J, Roberts D, Bush ZM (as Senior/corresponding author).

    Protective Effects of Lignite Extract Supplement on Intestinal Barrier Function in Glyphosate-mediated Tight Junction Injury.

    [Self-Funded Original Research]

    (Under Review - BioMed Central – Public Health).

Projects

  • NIH LRP Grant: Neuroimaging, Inflammation, and Endocrine Profiles in Human Subjects with Major Depressive Disorder.

    NIH LRP Grant.

    Neuroimaging, Inflammation, and Endocrine Profiles in Human Subjects with Major Depressive Disorder.

    PI: Bush ZM.

    July, 2007

  • Individual Ruth L. Kirschstein National Research Service Award

    -

    Individual Ruth L. Kirschstein National Research Service Award (NRSA) 1-F32-DK082159-01.

    Retinoic Acid Receptors: A Novel Therapeutic Target for Cushing’s Disease.

    PI: Bush ZM.

    Funding period: August, 2008 – July, 2010

    $115,560 direct cost

  • NIH LRP grant

    -

    NIH LRP grant: PI: Bush ZM.

    July, 2008 - June 2010.

    $55,508 direct cost

  • CTSA Novel Pilot Study Award

    -

    CTSA Novel Pilot Study Award. Retinoid- Mediated Apoptosis: a novel therapeutic approach to the management of Cushing’s disease. Author and lead investigator: Bush ZM.

    Faculty Sponsor: Mary Lee Vance.

    Funding cycle 3/09-03/10, potential for renewal.

    $25,000 direct cost

  • ACP Leadership: Associate Physician Delegate, 5th Congressional District, Virginia

    -

    Represented 5th district on Capitol Hill, May, 2008 and May, 2009

  • Institutional Ruth L. Kirschstein National Research Service Award

    -

    Institutional Ruth L. Kirschstein National Research Service Award (NRSA) 1-T32-DK07646. PI: Robert Carey.

    Funding period: September, 2007- July, 2008.

    $47,000 direct cost support

  • COUP-TFI and COUP-TFII expression in breast cancer cell lines, opportunities for apoptotic synergy.

    -

    COUP-TFI and COUP-TFII expression in breast cancer cell lines, opportunities for apoptotic synergy. I have demonstrated decreased expression of COUP-TFI and COUP-TFII in two post-menopausal cell lines
    (MCF-7 and a Tamoxifen-resistant line), with complete absence noted in pre-menopausal ICI-resistant cells. This finding not only identifies tumor populations that may be vulnerable to retinoic acid therapy, it also opens an avenue to explore pharmaceutical regulation of COUP-TF expression…

    COUP-TFI and COUP-TFII expression in breast cancer cell lines, opportunities for apoptotic synergy. I have demonstrated decreased expression of COUP-TFI and COUP-TFII in two post-menopausal cell lines
    (MCF-7 and a Tamoxifen-resistant line), with complete absence noted in pre-menopausal ICI-resistant cells. This finding not only identifies tumor populations that may be vulnerable to retinoic acid therapy, it also opens an avenue to explore pharmaceutical regulation of COUP-TF expression, which would have the potential to open up a broad array of solid tumors for adjuvant therapy with retinoic acid.

    PI: Bush ZM.

    Current collaborators: Richard Santen, MD. Ping Fan, PhD. Sarah Aiyar, PhD

  • Human Corticotroph Adenomas: Expression of RAR, RXR, COUP-TF, PPAR-gamma and Caspase 3 activity in corticotroph cells.

    -

    IRB#13313 Human Corticotroph Adenomas: Expression of RAR, RXR, COUP-TF, PPAR-gamma and Caspase 3 activity in corticotroph cells.

    PI: Bush ZM

  • Hyperlipidemic pancreatitis in HIV patients; the effects of protease inhibitor related hypertriglyceridemia.

    -

    Department of Endocrinology, University of Colorado Health Science Center, 2001-2002.

    Topic: Hyperlipidemic pancreatitis in HIV patients; the effects of protease inhibitor related hypertriglyceridemia.

    Mentors: Lisa Kosmiski, MD and Robert Eckel, MD

  • Preoperative Bexarotene Treatment for Cushing’s Disease.

    -

    IRB#13369; GCRC #2335.

    Preoperative Bexarotene Treatment for Cushing’s Disease.

    Author and lead scientific investigator: Bush ZM.

    PI: Vance

    ML (faculty PI required for GCRC study).

  • Prevalence of Vitamin D deficiency among patients with pituitary tumors.

    -

    IRB-HSR # 3943 Prevalence of Vitamin D deficiency among patients with pituitary tumors.

    Co-author and Co-investigator: Bush ZM.

    PI: Michael Thorner, MD, DSc

  • Retinoic Acid Receptors: A Novel Therapeutic Target for Cushing’s Disease.

    -

    Author and lead investigator: Bush ZM. Mentors and Collaborators: Mary Lee Vance M.D., Beatriz Lopez, M.D., Ph.D., Isa Hussaini Ph.D. John Jane, Jr, M.D., Edward Oldfield,

    Salary Support from NIH F32 NRSA grant.

    PI: Zachary Bush.

    Direct Costs: Umfrid neuroendocrinology

    Research Grant. PI: Mary Lee Vance; John Jane, Jr.

  • Umfrid Neuroendocrinology Research Fund

    -

    Umfrid Neuroendocrinology Research Fund.

    PI: Mary Lee Vance and John Jane, Jr.

    $107,000

Honors & Awards

  • UVA Novel Translational Research Award

    Clinical and Translational Science Awards

    CTSA Pilot Study award for my proof-of-concept clinical trial: Preoperative Bexarotene treatment for Cushing’s disease.

    One faculty awardee each year.

    $25,000.

  • ENDO 08 Trainee Poster Competition

    Endocrine Society

    Winner ENDO 08 Trainee Poster Competition

    Pituitary Diagnostics and Disease Management Section

    Immunohistochemisty of COUP-TFI: an Adjuvant Diagnostic Tool for the Identification of Corticotroph Microadenomas.

  • House Staff Resident/Fellow Teaching Award 2005-2006

    -

    I received a House Staff Resident/Fellow teaching award for 2005-2006.

  • Nominee: Inpatient Teaching Attending of the Year

    -

    I was nominated for the Inpatient Teaching Attending of the Year for 2005-2006.

  • Associates Abstract Contest

    Virginia American College of Physicians (ACP)

    Awarded in 2004 for Warfarin skin necrosis in a patient with antiphospholipid syndrome, a case report.

    Presented at Regional and National ACP meetings spring of 2004.

  • Resident/Fellow Teaching Award

    -

    Nominee for 2004-2005.

  • Associates Research Poster Competition

    Virginia American College of Physicians (ACP)

    The prevalence and associated etiologies of acute pancreatitis in the HIV-infected population before and after the introduction of protease inhibitors.

  • James Waring Award

    -

    Awarded to the third-year medical student who has demonstrated diligent scholarship and devotion to the field of Internal Medicine”

  • The Levitt Prize

    -

    1st place recipient, University of Colorado; a University-wide competition among all literature courses – winning entry argumentative essay

  • Basic Science Honors

    -

    Anatomy, Cell Biology, Neurobiology, Embryology, Biochemistry of Nutrition, Immunology, Epidemiology/ Statistics

  • Clinical Honors

    -

    Internal Medicine, Internal Medicine Sub-Internship, Family Medicine, Pediatrics, General Surgery, Obstetrics/ Gynecology, Neurology, Psychiatry, Emergency Medicine, Endocrinology, Rheumatology, Hospice, Cardiac Diagnostics

  • Deans List

    -

    I was honored to be part of the Dean’s List during every semester of my Undergraduate degree.

Languages

  • Spanish

    -

  • English

    -

Organizations

  • Medicine Grand Rounds, UVA

    Invited Lecturer

    -

    “Glycemic Control in DM2, How Low Should You Go? DISCORD over ADVANCE and ACCORD.” An invitation typically reserved for UVA and visiting faculty

Recommendations received

More activity by Zach

View Zach’s full profile

  • See who you know in common
  • Get introduced
  • Contact Zach directly
Join to view full profile

Other similar profiles

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Add new skills with these courses